Insider Stock Trading History of Clarke David H


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Clarke David H since year 2005. The trader's CIK number is 1251818. At the time of this reporting, Clarke David H is the Former CEO and Director of Innovate Biopharmaceuticals, Inc. . (stock ticker symbol INNT). See this page for all insider trading activities at Innovate Biopharmaceuticals, Inc. .

Note that in the past CLARKE DAVID H also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Clarke David H since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-07-13 INNT Innovate Biopharmaceuticals, Inc. Buy 15,000 4.50 67,500
2018-01-26 INNT Innovate Biopharmaceuticals, Inc. Buy 300,000 .35 105,000
2017-11-29 INNT Innovate Biopharmaceuticals, Inc. Buy 366,159 .45 164,771
2017-03-16 INNT Innovate Biopharmaceuticals, Inc. Buy 70,000 1.50 105,000
2017-06-23 INNT Innovate Biopharmaceuticals, Inc. Buy 172,414 .58 100,000
2005-09-27 JJZ Jacuzzi Brands Inc Buy 50,000 7.33 366,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clarke David H (Former CEO and Director of Innovate Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.